Abiron Tablet

About Abiron 250 mg Tablet

Abiron 250 mg tablet is a cytotoxic medicine containing abiraterone acetate, used for certain advanced prostate cancers in men. It is taken with prednisone and a GnRH analog or after orchiectomy, as part of a doctor-led treatment plan.

There are 4 brands of Abiraterone Acetate listed in Bangladesh. 1 of them has a lower unit price than Abiron. The lowest listed price is Abiret 250 mg Tablet at ৳ 500.00 per unit.

What is Abiron 250 mg Tablet?

Abiron 250 mg tablet is a prescription medicine for men with metastatic castration-resistant prostate cancer or metastatic high-risk castration-sensitive prostate cancer. It contains abiraterone acetate, which works by blocking an enzyme involved in making androgens. It is used together with prednisone, and with a GnRH analog or after bilateral orchiectomy. Abiron is a cytotoxic chemotherapy medicine, so it should only be taken under the supervision of a cancer specialist. The doctor will decide the appropriate dose and course of treatment. The tablet strength is 250 mg, and the pack contains 28 tablets.

Uses of Abiron

Abiron 250 mg tablet is used in adult men for two types of advanced prostate cancer: metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer. It is given in combination with prednisone. Patients should also receive a GnRH analog or have had bilateral orchiectomy. It is not for use in women or children. Your doctor will confirm whether this treatment is suitable for your condition.

How to use Abiron

Swallow the tablet whole with water; do not crush or chew it. Take it on an empty stomach, at least 1 hour before or 2 hours after a meal. The doctor will decide the dose, the timing, and how long you take Abiron, and may adjust it based on your health and other medicines. Do not change the dose yourself. Always follow your doctor's instructions and keep all appointments for monitoring.

Side effects of Abiron

Common side effects include fatigue, joint pain, high blood pressure, nausea, swelling, low potassium, hot flushes, diarrhoea, vomiting, upper respiratory infection, cough, and headache. More serious effects can include liver problems, adrenal insufficiency, and fluid retention. Your doctor will monitor you for these. Tell your doctor or pharmacist if you notice any side effects or if they bother you. Do not stop the medicine without medical advice.

Safety and precautions

Abiron is not for use in women, and its safety in pregnancy and breastfeeding has not been established. Based on animal studies and how it works, it may harm a fetus and cause pregnancy loss. There is no human data on use in pregnancy, and it is not known if it passes into breast milk. Men should ask their doctor about fertility and precautions. Before starting, tell your doctor if you have heart disease, high blood pressure, low potassium, liver problems, or are taking other medicines, as dose changes may be needed. The doctor will monitor blood pressure, potassium, and liver function regularly.

Frequently asked questions

How should Abiron be taken?

Take it whole with water on an empty stomach, at least 1 hour before or 2 hours after food. The doctor decides the dose and how long you take it. Do not crush or chew the tablet, and do not change the dose without asking your doctor, as the doctor will tailor the course to you.

What is Abiron used for and what kind of medicine is it?

Abiron 250 mg tablet is a cytotoxic chemotherapy medicine containing abiraterone acetate. It is used in men with metastatic castration-resistant prostate cancer or metastatic high-risk castration-sensitive prostate cancer, together with prednisone and a GnRH analog or after orchiectomy. It is not for women or children.

Is Abiron safe in pregnancy or breastfeeding?

Abiron is not for use in women. Its safety in pregnancy and breastfeeding has not been established. Animal studies and its mechanism suggest it can harm a fetus and cause pregnancy loss. There is no human data on pregnancy, and it is not known if it passes into breast milk. Ask your doctor for advice.

What is the price of Abiron?

The listed price is ৳ 520.00. For the exact current price and availability, please check with your pharmacy or the place where you plan to buy it, as prices may change.

Indications

Abiron is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with
  • Metastatic castration-resistant prostate cancer (CRPC).
  • Metastatic high-risk castration-sensitive prostate cancer (CSPC).

Pharmacology

Abiraterone Acetate is converted in vivo to Abiraterone, an androgen biosynthesis inhibitor, that inhibits 17 α-hydroxylase/C17, 20-lyase (CYP17). This enzyme is expressed in testicular, adrenal, and prostatic tumor tissues and is required for androgen biosynthesis. CYP17 catalyzes two sequential reactions:

1. The conversion of pregnenolone and progesterone to their 17 α-hydroxy derivatives by 17 α-hydroxylase activity and

2. The subsequent formation of dehydroepiandrosterone (DHEA) and androstenedione, respectively, by C17, 20 lyase activity. DHEA and androstenedione are androgens and are precursors of testosterone. Inhibition of CYP17 by Abiraterone can also result in increased mineralocorticoid production by the adrenals. Androgen sensitive prostatic carcinoma responds to treatment that decreases androgen levels. Androgen deprivation therapies, such as treatment with GnRH agonists or orchiectomy, decrease androgen production in the testes but do not affect androgen production by the adrenals or in the tumor.

Abiraterone Acetate decreased serum testosterone and other androgens in patients in the placebo-controlled clinical trial. It is not necessary to monitor the effect of Abiraterone Acetate on serum testosterone levels. Changes in serum prostate specific antigen (PSA) levels may be observed but have not been shown to correlate with clinical benefit in individual patients.

Dosage & Administration

Recommended Dose For Metastatic CRPC: The recommended dose of Abiraterone Acetate is 1,000 mg (two 500 mg tablets or four 250 mg tablets) orally once daily with Prednisone 5 mg orally twice daily.

Recommended Dose For Metastatic High-Risk CSPC: The recommended dose of Abiraterone Acetate is 1,000 mg (two 500 mg tablets or four 250 mg tablets) orally once daily with Prednisone 5 mg administered orally once daily.

Patients receiving Abiraterone Acetate should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had bilateral orchiectomy. Abiraterone Acetate must be taken on an empty stomach, at least one hour before or at least two hours atier a meal. The tablets should be swallowed whole with water. Do not crush or chew tablets.

Dose Modification:
  • For patients with baseline moderate hepatic impairment (Child-Pugh Class B), reduce the Abiraterone Acetate starting dose to 250 mg once daily.
  • For patients who develop hepatotoxicity during treatment, hold Abiraterone Acetate until recovery. Retreatment may be initated at a reduced dose. Abiraterone Acetate should be discontinued if patients develop severe hepatotoxicity.
  • Avoid concomitant strong CYP3A4 inducers (e.g., Phenytoin, Carbamazepine, Rifampin, Rifabutin, Rifapentine, Phenobarbital) during Abiraterone Acetate treatment. If a strong CYP3A4 inducer must be co-administered, increase the Abiraterone Acetate dosing frequency to twice a day only during the co-administration period (e.g., from 1,000 mg once daily to 1,000 mg twice a day). Reduce the dose back to the previous dose and frequency, if the concomitant strong CYP3A4 inducer is discontinued. Or, as directed by the registered physician.
Pediatric Use: The safety and effectiveness in pediatric patients have not been established.

Interaction

Drugs That Inhibit Or Induce CYP3A4 Enzymes: Based on in vitro data, Abiron is a substrate of CYP3A4. In a dedicated drug interaction trial, co-administration of Rifampin, a strong CYP3A4 inducer, decreased exposure of Abiron by 55%. Avoid concomitant strong CYP3A4 inducers during Abiron treatment. If a strong CYP3A4 inducer must be co-administered, increase the Abiron dosing frequency. In a dedicated drug interaction trial, co-administration of ketoconazole, a strong inhibitor of CYP3A4, had no clinically meaningful effect on the pharmacokinetics of Abiron.

Effects Of Abiron On Drug Metabolizing Enzymes: Abiron is an inhibitor of the hepatic drug-metabolizing enzymes CYP2D6 and CYP2C8. In a CYP2D6 drug-drug interaction trial, the Cmax and AUC of Dextromethorphan (CYP2D6 substrate) were increased 2.8- and 2.9-fold, respectively, when Dextromethorphan was given with Abiron 1,000 mg daily and Prednisone 5 mg twice daily. Avoid co-administration of Abiron with substrates of CYP2D6 with a narrow therapeutic index (e.g., Thioridazine). If alternative treatments cannot be used, consider a dose reduction of the concomitant CYP2D6 substrate drug. In a CYP2C8 drug-drug interaction trial in healthy subjects, the AUC of Pioglitazone (CYP2C8 substrate) was increased by 46% when Pioglitazone was given together with a single dose of 1,000 mg Abiron. Therefore, patients should be monitored closely for signs of toxicity related to a CYP2C8 substrate with a narrow therapeutic index if used concomitantly with Abiron.

Contraindications

Hypersensitivity to the Abiraterone acetate or to any of the excipients of Abiraterone.

Side Effects

The most common adverse reactions are fatigue, arthalgia, hypertension, nausea, edema, hypokalemia, hot flush, diarrhea, vomiting, upper respiratory infection, cough, and headache.

Pregnancy & Lactation

The safety and efficacy of Abiraterone have not been established in females. Based on findings from animal studies and the mechanism of action, Abiraterone can cause fetal harm and potential loss of pregnancy. There are no human data on the use of Abiraterone in pregnant women. The safety and efficacy of Abiraterone have not been established in females. There is no information available on the presence of abiraterone acetate in human milk, or on the effects on the breastfed child or milk production.

Precautions & Warnings

Abiron may cause hypertension, hypokalemia, and fluid retention as a consequence of increased mineralocorticoid levels resulting from CYP17 inhibition. Patients should be monitored for hypertension, hypokalemia, and fluid retention at least once a month. Hypertension and hypokalemia should be controlled and corrected before and during treatment with Abiron. Patients should be monitored for symptoms and signs of adrenocortical insufficiency. Serum transaminases (ALT and AST) and bilirubin levels should be measured prior to starting treatment with Abiron, every two weeks for the first three months of treatment and monthly thereatier.

Overdose Effects

There is no specific antidote. In the event of an overdose, Abiron should be stopped, general supportive measures are undertaken, including monitoring for arrhythmias and cardiac failure and assess liver function.

Storage Conditions

Do not store above 25°C. Protect from light. Keep out of the reach of children.

Alternative brands of Abiraterone Acetate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.